Intellipharmaceutics International Inc. (IPCI)

[InTheTrenches]

I agree that debt financing is very possible at this point and the most likely way to raise capital, if IPCI decides to go this route (mfg, marketing in-house). Especially if good Focalin numbers are reported for Q1.

However, I'm not sure I agree on Rexista. Getting a large, well-placed partner seems the right path here. Zogenix seemed to be doing well alone initially, but they're now hitting a wall, as there are many big pharma names that have more clout on Capital Hill than ZGNX. Might be best to have large pharma backing when trying to navigate this arena.

Additionally, there will be competitors in this space, so it will help to have an experienced marketer (large pharma) in this space.